Similar articles

• Glycogen storage disease type II (Pompe's disease): the first biochemical evidence in Thailand.

  Rangdaeng S, Scollard DM, Srichairatanakol S, Sutthachit M, Phornphutkul C. Rangdaeng S, et al. J Med Assoc Thai. 1987 Sep;70(9):536-42. J Med Assoc Thai. 1987. PMID: 2960768 No abstract available.
• [Biochemical diagnosis of glycogenosis type II (acid maltase deficiency) (author's transl)].

  Pilz H, Goebel HH, Stefan H, Seidel D, Kohlschütter A. Pilz H, et al. J Clin Chem Clin Biochem. 1977 Dec;15(12):705-8. J Clin Chem Clin Biochem. 1977. PMID: 342670 German. No abstract available.
• Comparative investigation of alpha-glucosidase activity in leucocytes and skeletal muscle of patients with Morbus Pompe.

  Didt L, Winkler M, Bührdel P, Bormann M, Böhme HJ, Hofmann E. Didt L, et al. Z Med Lab Diagn. 1988;29(1):7-11. Z Med Lab Diagn. 1988. PMID: 3129881 No abstract available.
• Treatment related observations in solid tissues, fibroblast cultured and amniotic fluid cells of type II glycogenosis, Hurler disease and metachromatic leukodystrophy.

  Hug G, Schubert WK, Soukup S. Hug G, et al. Birth Defects Orig Artic Ser. 1973 Mar;9(2):160-83. Birth Defects Orig Artic Ser. 1973. PMID: 4215475 Review. No abstract available.
• The lysosome: a role in disease.

  Verity MA, Andiman R, Munsat TL, Smith RE, Szego CM. Verity MA, et al. Ann Intern Med. 1973 May;78(5):725-38. doi: 10.7326/0003-4819-78-5-725. Ann Intern Med. 1973. PMID: 4351255 Review. No abstract available.